These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28223316)

  • 61. IRF7 regulates the development of granulocytic myeloid-derived suppressor cells through S100A9 transrepression in cancer.
    Yang Q; Li X; Chen H; Cao Y; Xiao Q; He Y; Wei J; Zhou J
    Oncogene; 2017 May; 36(21):2969-2980. PubMed ID: 28092673
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Epigenetics in myeloid derived suppressor cells: a sheathed sword towards cancer.
    Zhang C; Wang S; Liu Y; Yang C
    Oncotarget; 2016 Aug; 7(35):57452-57463. PubMed ID: 27458169
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Modulation of myeloid-derived suppressor cell functions by oral inflammatory diseases and important oral pathogens.
    García-Arévalo F; Leija-Montoya AG; González-Ramírez J; Isiordia-Espinoza M; Serafín-Higuera I; Fuchen-Ramos DM; Vazquez-Jimenez JG; Serafín-Higuera N
    Front Immunol; 2024; 15():1349067. PubMed ID: 38495880
    [TBL] [Abstract][Full Text] [Related]  

  • 64. CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients.
    Dubinski D; Wölfer J; Hasselblatt M; Schneider-Hohendorf T; Bogdahn U; Stummer W; Wiendl H; Grauer OM
    Neuro Oncol; 2016 Jun; 18(6):807-18. PubMed ID: 26578623
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The role of myeloid derived suppressor cells in musculoskeletal disorders.
    Ren Y; Bäcker H; Müller M; Kienzle A
    Front Immunol; 2023; 14():1139683. PubMed ID: 36936946
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Energy metabolism manipulates the fate and function of tumour myeloid-derived suppressor cells.
    Hu C; Pang B; Lin G; Zhen Y; Yi H
    Br J Cancer; 2020 Jan; 122(1):23-29. PubMed ID: 31819182
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Expansion of myeloid-derived suppressor cells promotes differentiation of regulatory T cells in HIV-1+ individuals.
    Wang L; Zhao J; Ren JP; Wu XY; Morrison ZD; Elgazzar MA; Ning SB; Moorman JP; Yao ZQ
    AIDS; 2016 Jun; 30(10):1521-1531. PubMed ID: 26959508
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.
    Parker KH; Beury DW; Ostrand-Rosenberg S
    Adv Cancer Res; 2015; 128():95-139. PubMed ID: 26216631
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Inhibition of Inflammatory Cytokines and Induction of Myeloid-Derived Suppressor Cells by the Effects of Granulocyte and Monocyte Adsorption Apheresis.
    Sakanoue M; Higashi Y; Kanekura T
    Ther Apher Dial; 2017 Dec; 21(6):628-634. PubMed ID: 28941055
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Frontline Science: Myeloid cell-specific deletion of Cebpb decreases sepsis-induced immunosuppression in mice.
    McPeak MB; Youssef D; Williams DA; Pritchett CL; Yao ZQ; McCall CE; El Gazzar M
    J Leukoc Biol; 2017 Aug; 102(2):191-200. PubMed ID: 28476751
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Signal transducer and activator of transcription proteins: regulators of myeloid-derived suppressor cell-mediated immunosuppression in cancer.
    Ko HJ; Kim YJ
    Arch Pharm Res; 2016 Nov; 39(11):1597-1608. PubMed ID: 27572156
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Frequency of Myeloid-derived Suppressor Cells in the Peripheral Blood Reflects the Status of Tumor Recurrence.
    Tanaka T; Fujita M; Hasegawa H; Arimoto A; Nishi M; Fukuoka E; Sugita Y; Matsuda T; Sumi Y; Suzuki S; Kakeji Y; Yamashita K
    Anticancer Res; 2017 Jul; 37(7):3863-3869. PubMed ID: 28668887
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Emerging avenues linking myeloid-derived suppressor cells to periodontal disease.
    Leija-Montoya AG; González-Ramírez J; Serafín-Higuera I; Sandoval-Basilio J; Isiordia-Espinoza M; Serafín-Higuera N
    Int Rev Cell Mol Biol; 2023; 375():165-189. PubMed ID: 36967152
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Myeloid suppressor cells in cancer and autoimmunity.
    Sica A; Massarotti M
    J Autoimmun; 2017 Dec; 85():117-125. PubMed ID: 28728794
    [TBL] [Abstract][Full Text] [Related]  

  • 75. IFN regulatory factor 8 represses GM-CSF expression in T cells to affect myeloid cell lineage differentiation.
    Paschall AV; Zhang R; Qi CF; Bardhan K; Peng L; Lu G; Yang J; Merad M; McGaha T; Zhou G; Mellor A; Abrams SI; Morse HC; Ozato K; Xiong H; Liu K
    J Immunol; 2015 Mar; 194(5):2369-79. PubMed ID: 25646302
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Myeloid-Derived Suppressor Cells in Cancers and Inflammatory Diseases: Angel or Demon?
    Su Z; Ni P; Zhou C; Wang J
    Scand J Immunol; 2016 Nov; 84(5):255-261. PubMed ID: 27541573
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Suppressive role of myeloid-derived suppressor cells (MDSCs) in the microenvironment of breast cancer and targeted immunotherapies.
    Shou D; Wen L; Song Z; Yin J; Sun Q; Gong W
    Oncotarget; 2016 Sep; 7(39):64505-64511. PubMed ID: 27542274
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Chemotherapy alters the increased numbers of myeloid-derived suppressor and regulatory T cells in children with acute lymphoblastic leukemia.
    Salem ML; El-Shanshory MR; Abdou SH; Attia MS; Sobhy SM; Zidan MF; Zidan AA
    Immunopharmacol Immunotoxicol; 2018 Apr; 40(2):158-167. PubMed ID: 29388481
    [TBL] [Abstract][Full Text] [Related]  

  • 79. MMP-9-cleaved osteopontin isoform mediates tumor immune escape by inducing expansion of myeloid-derived suppressor cells.
    Shao L; Zhang B; Wang L; Wu L; Kan Q; Fan K
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1478-1484. PubMed ID: 28986261
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Vasoactive intestinal peptide induces CD14+HLA-DR‑/low myeloid-derived suppressor cells in gastric cancer.
    Li G; Wu K; Tao K; Lu X; Ma J; Mao Z; Li H; Shi L; Li J; Niu Y; Xiang F; Wang G
    Mol Med Rep; 2015 Jul; 12(1):760-8. PubMed ID: 25695487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.